Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

King & Spalding announce appointment of former FDA official

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Eva Temkin, a former senior FDA official for therapeutic biologics and biosimilars, has joined King & Spalding in Washington, US, …
Appointment

Are we on the cusp of an AI revolution?

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …
Feature

Navigating through the post-COVID-19 R&D bottleneck

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Jack Goddard inve
Feature
Top 10 news roundup

Phamafile.com’s top 10 news stories of the week

April 23, 2021 Medical Communications COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma, pharma news

Among our top 10 stories this week: A study has found the Pfizer COVID-19 vaccine to have a significantly reduced …
News

Researchers find possible new treatment for several cancers

April 23, 2021 Medical Communications Cancer, The Institute of Cancer Research, cancer treatment, kidney cancer treatment, pharma, pharma news

Researchers at The Institute of Cancer Research (ICR) in London have discovered a new use for an ovarian and breast …
News
lonza

Lonza to invest over £150 million on new molecule complex

April 23, 2021 Medical Communications Lonza

Lonza have announced the construction of a new small molecule manufacturing complex at its Visp site in Switzerland, which will …
News
img_4190-e1376666350337-web

MHRA gives green light to new cardiovascular treatment

April 23, 2021 Medical Communications MHRA, cardiovascular

The MHRA has granted a Great Britain Marketing Authorisation for Vazkepa (icosapent ethyl) as a treatment to reduce the risk …
News
az

AstraZeneca drug evaluated in nine eosinophilic diseases

April 23, 2021 Medical Communications AstraZeneca

AstraZeneca announced on Thursday that the first patients had been dosed in the Phase III Fasenra (benralizumab) clinical trial in …
News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 16, 2021 Medical Communications covid 19 news, covid-19 news, news roundup, pharma, pharma news

A number of new COVID-19 developments have dominated the news again this week: J&J’s vaccine for the virus has been …
News

MHRA grants marketing authorisation for new formulation of Tysabri

April 16, 2021 Medical Communications MHRA

Biogen UK has been granted marketing authorisation by the MHRA for a subcutaneous (SC) injection of Tysabri (natalizumab), for adults …
News

Merck cease development of $425 million COVID-19 treatment

April 16, 2021 Medical Communications COVID-19, MSD, Merck, covid-19 treatment, pharma, pharma news

Merck (MSD) have ended the development of their MK-7110 drug for the treatment of hospitalised patients with COVID-19.
News

EMA to begin review of GSK and Vir’s COVID-19 treatment

April 16, 2021 Medical Communications COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir

The EMA have begun a review of GSK and Vir Biotechnology’s investigational COVID-19 antibody (VIR-7831) for patients at high risk …
News
andrei_r_-_shutterstock_1935537274_720

Thermo Fisher to acquire PPD in $17 billion deal

April 16, 2021 Medical Communications thermo fisher

Medical device maker Thermo Fisher Scientific announced it would acquire contract research organisation PPD Inc for $17.4 billion, as it …
News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 9, 2021 Medical Communications covid 19 news, covid-19 news, news, news roundup, pharma, pharma news

A number of new COVID-19 developments have emerged in April already: AstraZeneca has halted the trial of its COVID-19 vaccine …
News

Exscientia enter first-ever AI cancer drug into Phase I trials

April 9, 2021 Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news

Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025